- Home
- ACLS vs ARWR Comparison
ACLS vs ARWR Comparison
Compare ACLS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- ARWR
- Stock Information
- Founded
- ACLS 1995
- ARWR 2003
- Country
- ACLS United States
- ARWR United States
- Employees
- ACLS N/A
- ARWR N/A
- Industry
- ACLS Industrial Machinery/Components
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- ACLS Technology
- ARWR Health Care
- Exchange
- ACLS Nasdaq
- ARWR Nasdaq
- Market Cap
- ACLS 1.8B
- ARWR 1.7B
- IPO Year
- ACLS 2000
- ARWR 1993
- Fundamental
- Price
- ACLS $41.92
- ARWR $10.85
- Analyst Decision
- ACLS Buy
- ARWR Buy
- Analyst Count
- ACLS 7
- ARWR 11
- Target Price
- ACLS $156.00
- ARWR $41.44
- AVG Volume (30 Days)
- ACLS 628.6K
- ARWR 1.7M
- Earning Date
- ACLS 04-30-2025
- ARWR 05-08-2025
- Dividend Yield
- ACLS N/A
- ARWR N/A
- EPS Growth
- ACLS N/A
- ARWR N/A
- EPS
- ACLS 6.15
- ARWR N/A
- Revenue
- ACLS $1,017,865,000.00
- ARWR $2,500,000.00
- Revenue This Year
- ACLS N/A
- ARWR $4,380.43
- Revenue Next Year
- ACLS $11.97
- ARWR $58.72
- P/E Ratio
- ACLS $7.28
- ARWR N/A
- Revenue Growth
- ACLS N/A
- ARWR N/A
- 52 Week Low
- ACLS $44.79
- ARWR $11.61
- 52 Week High
- ACLS $158.61
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- ACLS 23.51
- ARWR 25.31
- Support Level
- ACLS $47.23
- ARWR $14.69
- Resistance Level
- ACLS $51.38
- ARWR $15.65
- Average True Range (ATR)
- ACLS 2.16
- ARWR 0.73
- MACD
- ACLS -0.77
- ARWR -0.19
- Stochastic Oscillator
- ACLS 0.00
- ARWR 0.12
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.